BYD Company Limited
002594
Hanshow Technology
301275
Orient Group Incorporation
600811
4
Kweichow Moutai
600519
5
Contemporary Amperex Technology
300750
CN Stock MarketDetailed Quotes
002915 Zhejiang Zhongxin Fluoride Materials
- 14.17
- -0.05-0.35%
Not Open Mar 11 15:00 CST
4.61BMarket Cap-23.86P/E (TTM)
14.30High13.97Low78.73KlotVolume14.07Open14.22Pre Close111.12MTurnover2.73%Turnover RatioLossP/E (Static)325.47MShares17.5752wk High3.20P/B4.09BFloat Cap8.5752wk Low15.64Limit Up288.31MShs Float27.29Historical High12.80Limit Down2.32%Amplitude3.00Historical Low--Dividend TTM14.11Avg Price41.22KlotAsk--Div YieldTTM100Lot Size35.91KlotBid
Zhejiang Zhongxin Fluoride Materials News
Zhejiang Zhongxin Fluoride Materials (002915.SZ): Focused on developing new types of Electrolyte products.
On March 4, Gelonghui reported that Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company adheres to technology leadership, deeply engaging in the field of fluorochemistry, and is committed to building core competencies with competitive advantages in the industry. In the field of fluoride new energy materials, the company is concentrating its efforts on developing new electrolyte products, and related research and development projects are progressing in an orderly manner. For specific research and development progress, please pay attention to the company's regular reports.
Zhejiang Zhongxin Fluoride Materials (002915.SZ): An integrated PEEK core raw material industry layout has been established.
On March 4th, Gelonghui reported that Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that in terms of polyether ether ketone (PEEK), the company has established an integrated industrial layout for PEEK core raw materials. Among them, the DFBP product has received quality certification from multiple domestic and foreign customers, and has already obtained bulk Orders from some domestic and foreign clients. As DFBP is the core monomer for synthesizing PEEK, its demand benefits, on one hand, from the gradual expansion of traditional applications in medical instruments materials and electronic and electrical materials, and on the other hand, from the expansion of applications in emerging fields for Lightweight materials. The company will closely monitor the situation.
Is Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) A Risky Investment?
Zhongxin Fluoride: 2024 Annual Results Forecast
Zhejiang Zhongxin Fluoride Materials (002915.SZ): Expected pre-loss of 0.18 billion yuan to -0.2 billion yuan for the 2024 fiscal year.
Gelonghui, January 17丨Zhejiang Zhongxin Fluoride Materials (002915.SZ) announced the annual performance forecast for 2024. The net income attributable to shareholders of the listed company is expected to be a loss of 0.18 billion yuan – 0.2 billion yuan, compared to a loss of 0.188 billion yuan in the same period last year; the net income after deducting non-recurring gains and losses is expected to be a loss of 0.167 billion yuan – 0.185 billion yuan, compared to a loss of 0.179 billion yuan in the same period last year; the basic EPS is expected to be a loss of 0.5506 yuan/share – 0.6118 yuan/share; revenue is expected to be 1.4 billion yuan – 1.42 billion yuan. During the reporting period, the company increased its efforts to expand the market for intermediate business and fluorine fine chemical business.
Retail Investors Invested in Zhejiang Zhongxin Fluoride Materials Co.,Ltd (SZSE:002915) Copped the Brunt of Last Week's CN¥1.0b Market Cap Decline
Investors in Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) From Three Years Ago Are Still Down 44%, Even After 10% Gain This Past Week
10 consecutive trading limits! The big monster stock makes a comeback.
What exactly are you speculating about?
Zhejiang Zhongxin Fluoride Materials (002915.SZ): The company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development.
Gelonghui October 18th: Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development. Pharmaceutical intermediates are important chemical raw materials in the drug synthesis process, playing a key role in the research and development of new drugs. Currently, the company has formed pharmaceutical intermediates represented by the 2,3,4,5-tetrafluorobenzene series, nanosar acid, and trifluoroacetic acid series. It has a provincial-level small and medium-sized enterprise technology center, a provincial-level enterprise research institute - Zhejiang Zhongxin Fluoride Chemicals and New Materials Research Institute, dedicated to pharmaceutical intermediates.
Zhongxin Fluoride: Report for the third quarter of 2024
Zhejiang Zhongxin Fluoride Materials (002915.SZ) released its performance for the first three quarters, with a net loss of 42.99 million yuan.
zhejiang zhongxin fluoride materials (002915.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Zhejiang Zhongxin Fluoride Materials (002915.SZ): The net loss in the third quarter was 19.8661 million yuan.
Gelonghui October 17th | Zhejiang Zhongxin Fluoride Materials (002915.SZ) released the third quarter report of 2024, with a revenue of 0.382 billion yuan, a year-on-year increase of 14.70%; net income attributable to shareholders of the listed company -19.8661 million yuan; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses -19.9351 million yuan; basic earnings per share -0.0608 yuan.
Here's Why Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) Can Afford Some Debt
zhejiang zhongxin fluoride materials (002915.SZ): there is still no production of fluorinated argon, fluorinated krypton.
On September 30th, zhejiang zhongxin fluoride materials (002915.SZ) stated on the investor interaction platform that the company has not yet produced fluorinated argon or fluorinated krypton.
Zhejiang Zhongxin Fluoride Materials (002915.SZ): Currently, the company's trifluoromethyl series products do not include trifluoromethyl benzamide.
Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform on August 29 that the company has been engaged in the production and research of fluorine-containing fine chemicals for a long time. Its products are involved in areas such as anti-infection, diabetes, and antiviral. Currently, the company does not have the product (trifluoromethyl) benzamide in its trifluoromethyl series products. The company will continue to pay attention to the technological development and market demand of the industry and carry out research on related pharmaceutical intermediates technology and products.
Breakthrough in solid state battery technology stimulates rapid development of related industries.
① Penghui Energy's official WeChat announced that a major breakthrough in all-solid-state batteries is coming soon. The 2024 Penghui Energy Product Technology Conference will be held on August 28, and a series of major new products will be released soon. ② CITIC Construction Investment estimates that by 2025, the global market space for various types of solid-state batteries may reach tens to hundreds of GWH or 100 billion yuan.
Zhejiang Zhongxin Fluoride Materials: Summary of Half-Year Report in 2024.
Zhejiang Zhongxin Fluoride Materials: Half-year report for the year 2024.
Zhejiang Zhongxin Fluoride Materials (002915.SZ) released its first-half performance, with a loss of 23.1287 million yuan compared to a profit.
Zhejiang Zhongxin Fluoride Materials (002915.SZ) released its 2024 interim report, during which the company achieved revenue...
Investors in Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) From Three Years Ago Are Still Down 39%, Even After 13% Gain This Past Week